Regenerative Medical Technology Group Inc. (RMTG)

Market Cap	751.08K
Revenue (ttm)	4.84M
Net Income (ttm)	-3.59M
Shares Out	12.54M
EPS (ttm)	-0.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,210
Average Volume	4,682
Open	0.0531
Previous Close	0.0579
Day's Range	0.0531 - 0.0531
52-Week Range	0.0210 - 0.0786
Beta	0.19
RSI	50.94
Earnings Date	Nov 21, 2025

About RMTG

Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: RMTG

Financial Performance

In 2024, RMTG's revenue was $4.11 million, an increase of 70.44% compared to the previous year's $2.41 million. Losses were -$5.56 million, -43.31% less than in 2023.